Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp

Laryngoscope

Volumn 123, Issue 6, 2013, Pages 1411-1415

  Cappello, Zachary J ^a   Augenstein, Adam C ^a   Potts, Kevin L ^a   McMasters, Kelly M ^a   Bumpous, Jeffrey M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Head and neck carcinoma, scalp; sentinel lymph nodes; Sunbelt Melanoma Trial

Indexed keywords

ALPHA2B INTERFERON;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SCALP MELANOMA; SENTINEL LYMPH NODE; SEX DIFFERENCE; SKIN ULCER; SKINFOLD THICKNESS;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NECK; NEOPLASM RECURRENCE, LOCAL; NORTH AMERICA; PROGNOSIS; PROSPECTIVE STUDIES; SCALP; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84878158163     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23793     Document Type: Article

References (15)

1. Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL,. Prognostic factors in head and neck melanoma: effect of lesion location. Cancer 1988; 62: 831-837.
2. Cole DJ, Mackay GJ, Walker BF, Wooden WA, Murray DR, Coleman JJ,. Melanoma of the external ear. J Surg Oncol 1992; 50: 110-114.
3. Byers RM, Smith JL, Russell N, Rosenberg V,. Malignant melanoma of the external ear: review of 102 cases. Am J Surg 1980; 140: 518-521.
4. Ballantyne AJ,. Malignant melanoma of the skin of the head and neck: an analysis of 405 cases. Am J Surg 1970; 120: 425-431.
5. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how may radioactive nodes should be removed? Ann Surg Oncol 2001; 8: 192-197.
6. Carlson GW, Murray DR, Lyles RH, Hestley A,CohenC. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma. Plast Reconstr Surg 2005; 115: 721-728.
7. Close LG, Goepfert H, Ballantyne AJ, Jesse RH,. Malignant melanoma of the scalp. Laryngoscope 1979; 89: 1189-1196.
8. Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical stage I patients: a prognostic factors analysis and results of surgical treatment. Ann Surg 1984; 200: 769-775.
9. Leong SP, Accortt NA, Essner R, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 2006; 132: 370-373.
10. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE,. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J Invest Dermatol 2008; 128: 243-245.
11. Day CL Jr, Mihm MC Jr, Sober AJ, et al. Prognostic factors for melanoma patents with lesions 0.76-1.69 mm in thickness: an appraisal of "thin" level IV lesions. Ann Surg 1982; 195: 30-34.
12. Cascinelli N, Vaglini M, Bufalino R, Morabito A,. BANS: a cutaneous region with no prognostic significance in patients with melanoma. Cancer 1986; 57: 441-444.
13. Gillgren P, Mansson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U,. A prospective population-based study of cutaneous malignant melanoma of the head and neck. Laryngoscope 2000; 110: 1498-1504.
14. Ringborg U, Afzelius LE, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck: analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer 1993; 71: 751-758.
15. Doting EH, De Vries M, Plukker JThM, et al. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol 2006; 93: 564-570.